DCAT Value Chain Insights

Clinical Trial Material Supply: The Impact of COVID-19

What has been the impact of the COVID-19 pandemic on clinical trials and thus supplying materials for these trials? DCAT Value Chain Insights takes an inside look and tracks the latest developments....

Executive Order Advances US-based Drug Production

President Donald Trump issued an executive order late last week (August 6, 2020) to increase US-based production and federal procurement of essential medicines, medical countermeasures, and critical...

SPONSORED CONTENT

A Cambrex Webinar - Understanding the Importance of Crystallization Processes to Avoid Unnecessary Cost, Risk and Development Delays

Information
June 8, 2020
Sponsored by Cambrex

Dr. Craig Callahan, Project Scientist, Cambrex Edinburgh, discusses the importance of understanding crystallization processes to avoid unnecessary cost, risk and development delays.

Read More
Overcoming Challenges to Deliver Fixed Dose Combination (FDC) Drug Products

Information
June 2, 2020
Sponsored by Cambrex

With Cambrex’s experience in combining two or more active pharmaceutical ingredients (APIs) into Fixed Dose Combination drugs (FDCs), we are the CDMO that’s expertly positioned to partner with you...

Read More
Q&A with Stephan Haitz, President, CDMO Sales & Marketing at Cambrex

Information
March 9, 2020
Sponsored by Cambrex

Stephan Haitz, President, CDMO Sales & Marketing discusses small molecule trends and how the CDMO industry is constantly evolving to meet the demands and needs of the growing clinical pipeline.

Read More